Stock vs Stock Comparison

CME Group Inc. vs JPMorgan Chase & Co.

CME wins the Tale of the Tape 6–3.

CME$250.53
JPM$300.96

🏆 Tale of the Tape

63
CMEJPM
62.5%Profitability (Net Margin)31.4%
23.4xValuation (P/E)14.3x
11.4%Efficiency (ROIC)
6/9Health (Piotroski F)3/9
0.6Safety (Altman Z)0.3
6.4%Growth (Rev YoY)7.3%
0.92Risk (Sharpe 1Y)1.29
5.91xBalance Sheet (D/E)11.21x
3.95%FCF Yield

Green = winner in each category. Higher is better except P/E (lower = cheaper).

Rolling Correlation

-0.009
252-Day Correlation
-0.021
126-Day Correlation

Low correlation — excellent diversification pair.

Fundamentals

MetricCMEJPM
Market Cap$98.8B$802.0B
P/E Ratio23.4x14.3x
Forward P/E21.2x12.7x
P/B3.72x2.33x
Dividend Yield1.90%2.00%
Beta0.261.02

Quantitative Metrics

MetricCMEJPM
DCF Fair Value$370.85
DCF Upside+23.4%
Piotroski F6/93/9
Altman Z0.580.30
Beneish M-2.55
FCF Yield3.95%
Net Debt/EBITDA-0.2x
ROIC11.4%
WACC7.9%8.8%
ROIC – WACC3.5pp
Gross Margin86.1%
Net Margin62.5%31.4%
Rev Growth YoY6.4%7.3%
Sharpe (1Y)0.921.29
Max Drawdown 3Y-24.4%
FCF Payout Ratio94%

CME Price

Loading chart...

JPM Price

Loading chart...

ETF Exposure

CME found in:

XLF1.41%
VFH1.23%
VFMV1.15%
QUS0.53%
MGV0.51%
VIG0.47%
VYM0.43%
VTV0.40%
SCHV0.39%
IWD0.35%
VONV0.32%
RSP0.21%
ESGV0.21%
SCHX0.18%
SCHB0.17%
VOO0.17%
IVV0.17%
SPYG0.17%
SPY0.16%
SPLG0.16%
VONE0.16%
SPYV0.16%
SPTM0.15%
VTI0.15%
ITOT0.15%
URTH0.13%
ACWI0.11%
VT0.09%
ONEO0.06%

JPM found in:

XLF11.08%
IYF10.78%
VFH9.53%
MGV3.96%
DIA3.71%
VIG3.59%
VYM3.34%
VTV3.11%
DGRO3.04%
SCHV2.76%
IWD2.63%
VONV2.46%
DGRW2.07%
SPYG1.59%
LRGF1.50%
ESGV1.50%
IVV1.50%
SPLG1.43%
ITOT1.33%
SCHX1.31%
VOO1.28%
SPY1.28%
SCHB1.23%
VONE1.22%
SPTM1.18%
VTI1.14%
DFAC1.00%
KBE0.98%
URTH0.97%
SPYV0.91%
ACWI0.88%
QUS0.85%
VT0.70%
VFMO0.23%
RSP0.19%
VFVA0.07%
VFMV0.02%

More Comparisons

Quant metrics computed from financial statements and 1,200+ trading days. Correlation is Pearson coefficient on daily log returns. Not investment advice.

CME vs JPM: Head-to-Head Analysis

CME Group Inc. (CME) and JPMorgan Chase & Co. (JPM) represent two companies in the Financial Services sector. In our quantitative Tale of the Tape scoring, CME leads 6–3 across nine fundamental and risk metrics including profitability, valuation, capital efficiency, and financial health.

The 252-day rolling correlation between CME and JPM is -0.009, indicating low correlation, making them an effective diversification pair in a portfolio context.

CME appears in 29 ETFs tracked by SecuritiesDB, while JPM appears in 37 ETFs. Investors holding broad-market ETFs may already have indirect exposure to both stocks.

Frequently Asked Questions

Which stock is the better investment, CME or JPM?

Our quantitative analysis compares CME and JPM across nine fundamental dimensions. CME wins the Tale of the Tape 6–3. However, stock selection depends on your individual risk tolerance, time horizon, and portfolio context. These metrics are computed from SEC filings and market data — they are not investment recommendations.

Are CME and JPM correlated?

The 252-day correlation between CME and JPM is -0.009. They have low correlation, offering good diversification.

How is the Tale of the Tape scored?

The Tale of the Tape compares both stocks across nine categories: profitability (net margin), valuation (P/E), efficiency (ROIC), health (Piotroski F-Score), safety (Altman Z-Score), growth (revenue YoY), risk (Sharpe ratio), leverage (debt-to-equity), and cash generation (FCF yield). The stock that wins more categories takes the overall score. Lower P/E and lower debt-to-equity count as wins.